logo mainlogo darklogo main
  • HOME
  • ABOUT
    • Our Story
    • Quality
    • Clients
  • PRODUCTS
    • APIs
      • APIs List
      • Amisulpride
      • Bilastine
      • Bedaquiline
      • Ethopabate
      • Vonoprazan
      • Rivaroxaban
      • Metoclopramide
      • Carvedilol
      • Silodosin
      • Dapagliflozin
      • Empagliflozin
      • Oseltamivir Phosphate
      • Carglumic Acid
      • Tofacitinib Citrate
      • Posaconazole
      • Nirmatrelvir
      • Bumetanide
      • Brivaracetam
      • Resmetirom
    • Drug Intermediates
    • Biological
    • Reaction Capabilities
  • CSR
  • CONTACT
logo mainlogo darklogo main
  • HOME
  • ABOUT
    • Our Story
    • Quality
    • Clients
  • PRODUCTS
    • APIs
      • APIs List
      • Amisulpride
      • Bilastine
      • Bedaquiline
      • Ethopabate
      • Vonoprazan
      • Rivaroxaban
      • Metoclopramide
      • Carvedilol
      • Silodosin
      • Dapagliflozin
      • Empagliflozin
      • Oseltamivir Phosphate
      • Carglumic Acid
      • Tofacitinib Citrate
      • Posaconazole
      • Nirmatrelvir
      • Bumetanide
      • Brivaracetam
      • Resmetirom
    • Drug Intermediates
    • Biological
    • Reaction Capabilities
  • CSR
  • CONTACT
logo main logo darklogo light
  • HOME
  • ABOUT
    • Our Story
    • Quality
    • Clients
  • PRODUCTS
    • APIs
      • APIs List
      • Amisulpride
      • Bilastine
      • Bedaquiline
      • Ethopabate
      • Vonoprazan
      • Rivaroxaban
      • Metoclopramide
      • Carvedilol
      • Silodosin
      • Dapagliflozin
      • Empagliflozin
      • Oseltamivir Phosphate
      • Carglumic Acid
      • Tofacitinib Citrate
      • Posaconazole
      • Nirmatrelvir
      • Bumetanide
      • Brivaracetam
      • Resmetirom
    • Drug Intermediates
    • Biological
    • Reaction Capabilities
  • CSR
  • CONTACT
Tofacitinib vs Other JAK Inhibitors
July 17, 2025
Uncategorized

Tofacitinib vs Other JAK Inhibitors: A Comparative View for API Sourcing Professionals

Tofacitinib vs Other JAK Inhibitors: A Comparative View for API Sourcing Professionals The Janus Kinase (JAK) inhibitor class has revolutionized treatments across multiple chronic

Read More
July 17, 2025
Uncategorized

Form A vs Form B: Understanding Variants of Citrate-Based JAK Inhibitors in Pharma

Form A vs Form B: Understanding Variants of Citrate-Based JAK Inhibitors in Pharma   The evolution of targeted therapies in immunology and oncology has rapidly accelerated the

Read More
Interpreting the Specification Sheet
July 17, 2025
Uncategorized

Interpreting the Specification Sheet: Key Quality Metrics for Citrate-Based APIs

Interpreting the Specification Sheet: Key Quality Metrics for Citrate-Based APIs   In today’s complex pharmaceutical landscape, understanding citrate-based API specification

Read More
Kinase Inhibitor Powder Quality Guide
July 17, 2025
Uncategorized

Kinase Inhibitor Powder Quality Guide: What Distributors Must Verify Pre-Purchase

Kinase Inhibitor Powder Quality Guide: What Distributors Must Verify Pre-Purchase Pharmaceutical advancements in oncology, inflammation, and metabolic diseases have increasingly re

Read More
JAK Inhibitor API Certifications
July 17, 2025
Uncategorized

JAK Inhibitor API Certifications: DMF, GMP & CoA Explained

  JAK Inhibitor API Certifications: DMF, GMP & CoA Explained   The pharmaceutical landscape continues to rapidly evolve, particularly in the area of autoimmune and inflam

Read More
Tofacitinib Citrate API Pricing
July 17, 2025
Uncategorized

Tofacitinib Citrate API Pricing: Key Cost Factors in India

Tofacitinib Citrate API Pricing: Key Cost Factors in India   As demand for targeted therapies in autoimmune diseases and inflammatory conditions grows globally, Tofacitinib AP

Read More
Tofacitinib Citrate manufacturing
July 9, 2025
Uncategorized

2025 Trends in Kinase Inhibitor API Manufacturing: Spotlight on Tofacitinib Citrate

2025 Trends in Kinase Inhibitor API Manufacturing: Spotlight on Tofacitinib Citrate   In the dynamic global landscape of pharmaceutical development, the demand for high-qualit

Read More
Bilastine API in 25kg Drums
July 9, 2025
Uncategorized

Why Packaging Size Matters: Bilastine API in 25kg Drums

Why Packaging Size Matters: Bilastine API in 25kg Drums   In today’s competitive global pharmaceutical market, bulk procurement of Active Pharmaceutical Ingredients (APIs) r

Read More
CAS number of Bilastine
July 9, 2025
Uncategorized

What is the CAS number of Bilastine?

What is the CAS number of Bilastine? The global demand for high-quality Active Pharmaceutical Ingredients (APIs) continues to surge, particularly in therapeutic segments like aller

Read More
Bilastine’s use in allergy treatment
July 9, 2025
Uncategorized

What Is Bilastine Used For? Applications in Modern Allergy Treatment

What Is Bilastine Used For? Applications in Modern Allergy Treatment Allergic disorders continue to affect millions globally, leading to a sustained demand for safe, effective, and

Read More

Posts pagination

01 02
Bio synth

Biochemical & Synthetic
Products Private Limited

About
  • Our Story
  • Quality
  • Clients
  • CSR
  • Blogs
Products
  • APIs
  • Advanced Drug Intermediates
  • Biological
  • Reaction Capabilities
  • Product Intermediates
APIs List
  • Bedaquiline
  • Bilastine
  • Vonoprazan
  • Amisulpride
  • Metoclopramide
  • Ethopabate
  • Rivaroxaban
  • Carvedilol
  • Silodosin
  • Dapagliflozin
  • Empagliflozin
  • Oseltamivir Phosphate
  • Carglumic Acid
  • Tofacitinib Citrate
  • Nirmatrelvir
  • Posaconazole
  • Bumetanide
  • Brivaracetam
  • Resmetirom
Contact

Plot No. 11/6/2029, Phase 2, S.V.C.I.E, Balanagar, Hyderabad - 500037, Telangana, India

+91 77997 74402 (India)

info@bio-synth.com

© 2024 All Rights Reserved

  • →
  • Contact Us
    Contact Us

  • Phone
  • WhatsApp